ICARES Medicus Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 8.2yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For ICARES Medicus (GTSM:6612)
Mar 22
ICARES Medicus, Inc. (GTSM:6612) On An Uptrend: Could Fundamentals Be Driving The Stock?
Feb 24Would Shareholders Who Purchased ICARES Medicus' (GTSM:6612) Stock Year Be Happy With The Share price Today?
Jan 12
Here's What To Make Of ICARES Medicus' (GTSM:6612) Returns On Capital
Dec 15ICARES Medicus, Inc.'s (GTSM:6612) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Nov 24CEO
ICARES Medicus has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| VP and Head of Finance & Accounting Department | 8.2yrs | no data | no data | |
| Vice President of R&D and Operations | less than a year | no data | no data | |
| Chief R&D Officer & Director | no data | no data | 1.82% NT$ 98.7m | |
| President of Major Subsidiary | 9.9yrs | no data | no data | |
| Director | no data | no data | no data |
8.2yrs
Average Tenure
Experienced Management: 6612's management team is seasoned and experienced (8.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief R&D Officer & Director | 8.3yrs | no data | 1.82% NT$ 98.7m | |
| Director | 8.3yrs | no data | no data | |
| Chairman | 13.7yrs | no data | no data | |
| Independent Director | 8.3yrs | no data | no data | |
| Vice Chairman | 5.8yrs | no data | 4.72% NT$ 256.1m | |
| Independent Director | 7.8yrs | no data | no data |
8.3yrs
Average Tenure
Experienced Board: 6612's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/17 20:26 |
| End of Day Share Price | 2025/03/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ICARES Medicus, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| null null | KGI Securities Co. Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |